Connect Biopharma Holdings Limited (CNTB)

CNTB Statistics

Total Valuation

CNTB has a market cap or net worth of $55.25 million. The enterprise value is -$54.66 million.

Market Cap	55.25M
Enterprise Value	-54.66M

Important Dates

The last earnings date was Thursday, September 5, 2024, after market close.

Earnings Date	Sep 5, 2024
Ex-Dividend Date	n/a

Share Statistics

CNTB has 55.25 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	n/a
Shares Outstanding	55.25M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	21.98%
Owned by Institutions (%)	11.37%
Float	14.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.29
Forward PS	n/a
PB Ratio	0.50
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.04, with a Debt / Equity ratio of 0.00.

Current Ratio	12.04
Quick Ratio	11.82
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,114.70

Financial Efficiency

Return on equity (ROE) is -17.92% and return on invested capital (ROIC) is -13.38%.

Return on Equity (ROE)	-17.92%
Return on Assets (ROA)	-12.13%
Return on Capital (ROIC)	-13.38%
Revenue Per Employee	$297,728
Profits Per Employee	-$263,951
Employee Count	81
Asset Turnover	0.18
Inventory Turnover	n/a

Taxes

In the past 12 months, CNTB has paid $116,000 in taxes.

Income Tax	116,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.63% in the last 52 weeks. The beta is -0.31, so CNTB's price volatility has been lower than the market average.

Beta (5Y)	-0.31
52-Week Price Change	-20.63%
50-Day Moving Average	1.21
200-Day Moving Average	1.36
Relative Strength Index (RSI)	40.65
Average Volume (20 Days)	28,787

Short Selling Information

Short Interest	29,400
Short Previous Month	45,468
Short % of Shares Out	0.09%
Short % of Float	n/a
Short Ratio (days to cover)	1.23

Income Statement

In the last 12 months, CNTB had revenue of $24.12 million and -$21.38 million in losses. Loss per share was -$0.39.

Revenue	24.12M
Gross Profit	24.12M
Operating Income	-25.64M
Pretax Income	-59.38M
Net Income	-21.38M
EBITDA	-24.95M
EBIT	-25.64M
Loss Per Share	-$0.39

Balance Sheet

The company has $110.24 million in cash and $325,000 in debt, giving a net cash position of $109.92 million or $1.99 per share.

Cash & Cash Equivalents	110.24M
Total Debt	325,000
Net Cash	109.92M
Net Cash Per Share	$1.99
Equity (Book Value)	110.48M
Book Value Per Share	2.00
Working Capital	106.27M

Cash Flow

In the last 12 months, operating cash flow was -$24.75 million and capital expenditures -$441,000, giving a free cash flow of -$25.19 million.

Operating Cash Flow	-24.75M
Capital Expenditures	-441,000
Free Cash Flow	-25.19M
FCF Per Share	-$0.46

Margins

Gross margin is 100.00%, with operating and profit margins of -106.31% and -88.65%.

Gross Margin	100.00%
Operating Margin	-106.31%
Pretax Margin	-88.17%
Profit Margin	-88.65%
EBITDA Margin	-103.46%
EBIT Margin	-106.31%
FCF Margin	n/a

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.14%
Shareholder Yield	-0.14%
Earnings Yield	-38.69%
FCF Yield	-45.59%

Analyst Forecast

The average price target for CNTB is $8.00, which is 700.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	700.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	1.84%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CNTB has an Altman Z-Score of -1.56 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.56
Piotroski F-Score	1